LYVE1 and breast cancer: Overexpression of miR-655 in ER-positive BC cells gave rise to an increase in VEGF A, COX-2, and lymphatic vessel endothelial hyaluronan receptor-1 (LYVE1), along with increased migration and tubule formation in vitro [57].